Adverse drug reaction monitoring in Jena — experiences of a regionalized pharmacovigilance centre
- 30 September 1998
- journal article
- Published by Elsevier in Experimental and Toxicologic Pathology
- Vol. 50 (4-6) , 453-457
- https://doi.org/10.1016/s0940-2993(98)80033-x
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Who cares about pharmacovigilance?European Journal of Clinical Pharmacology, 1997
- Adverse drug reaction monitoring—cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admissionPharmacoepidemiology and Drug Safety, 1997
- Adverse drug reaction monitoring—cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissionsPharmacoepidemiology and Drug Safety, 1997
- Pharmacovigilance in the 1990sBritish Journal of Clinical Pharmacology, 1997
- Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortalityJAMA, 1997